title: Antithrombotic and thrombolytic therapy for valvular disease: can this guideline apply to Chinese?
authors: Department of Cardiac Surgery, West China Hospital, Sichuan University, Chengdu, China.
authors: Bo
authors: B
authors: Fu
authors: Department of Cardiac Surgery, West China Hospital, Sichuan University, Chengdu, China.
authors: Huaidong
authors: H
authors: Chen
authors: Department of Cardiac Surgery, West China Hospital, Sichuan University, Chengdu, China. Electronic address: donglikn199@163.com.
authors: Li
authors: L
authors: Dong
mesh_terms: D019317:Evidence-Based Medicine; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006349:Heart Valve Diseases / Q000150:complications* / Q000188:drug therapy*; D006470:Hemorrhage / Q000139:chemically induced* / Q000517:prevention & control*; D006801:Humans; D012955:Societies, Medical; D013923:Thromboembolism / Q000188:drug therapy* / Q000517:prevention & control*; D015912:Thrombolytic Therapy
chemical_list: D005343:Fibrinolytic Agents